UK MHRA MD Guidance: Borderlines with Medical Devices & Other Products in Great Britain
UK MHRA Guidance: Clinical Trials for Medicines: Apply for Authorisation in the UK
MHRA Guidance: 150-Day Assessment for National Applications & Parallel Import Licence
UK MHRA: Med Dev Guidance on "Off-Label Use","Virtual Mfg." "Legal Requirements" & "Approved Bodies"
UK MHRA: Guidance on Qualified Person responsible for QPPV & PSMF
UK MHRA Guidance: Notifying MHRA on a Clinical Investigation for a Medical Device
MHRA Guidance: Registration & Regulating Medical Devices in UK
UK MHRA: Guidance on Good Clinical Practice for Clinical Trials
UK MHRA: MHRA Fees 2023 & Guidance on How to Draft a Direct Health Care Professional Communication
UK MHRA: Guidance on Register Medical Devices to place on the Market
UK MHRA: MD Guidance on Crafting an Intended Purpose in the Context of SaMD
MHRA Guidance: Innovative Licensing and Access Pathway (updation)
UK MHRA: MD Guidance - Register Medical Devices to Place on the Market
UK MHRA: Guidance on EC Decision Reliance Procedure Extended till 31 Dec, 2023 & Nitrosamine Risk
MHRA Guidance: Licensing of Biosimilar Products
UK MHRA: 150-Day Assessment for National Applications
UK MHRA Guidance: Register to Manufacture, Import or Distribute Act.Sub, & Reclassify Products
UK's MHRA Guidance: Software & AI as a Medical Device Change Programme
UK MHRA Guidance: How to get a Parallel Import Licence in UK
MHRA Guidance: Export Drugs & Medicine, Active substances Manufactured in GB for use in EEA & NI